BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16288053)

  • 61. NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells.
    Wagner M; Koslowski M; Paret C; Schmidt M; Türeci O; Sahin U
    BMC Cancer; 2013 Dec; 13():570. PubMed ID: 24304549
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Checkpoint suppressor 1 suppresses transcriptional activity of ERα and breast cancer cell proliferation via deacetylase SIRT1.
    Xu Z; Yang Y; Li B; Li Y; Xia K; Yang Y; Li X; Wang M; Li S; Wu H
    Cell Death Dis; 2018 May; 9(5):559. PubMed ID: 29752474
    [TBL] [Abstract][Full Text] [Related]  

  • 63. TWIST represses estrogen receptor-alpha expression by recruiting the NuRD protein complex in breast cancer cells.
    Fu J; Zhang L; He T; Xiao X; Liu X; Wang L; Yang L; Yang M; Zhang T; Chen R; Xu J
    Int J Biol Sci; 2012; 8(4):522-32. PubMed ID: 22457607
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Cyclin D1 antagonizes BRCA1 repression of estrogen receptor alpha activity.
    Wang C; Fan S; Li Z; Fu M; Rao M; Ma Y; Lisanti MP; Albanese C; Katzenellenbogen BS; Kushner PJ; Weber B; Rosen EM; Pestell RG
    Cancer Res; 2005 Aug; 65(15):6557-67. PubMed ID: 16061635
    [TBL] [Abstract][Full Text] [Related]  

  • 65. IFI27/ISG12 Downregulates Estrogen Receptor α Transactivation by Facilitating Its Interaction With CRM1/XPO1 in Breast Cancer Cells.
    Cervantes-Badillo MG; Paredes-Villa A; Gómez-Romero V; Cervantes-Roldán R; Arias-Romero LE; Villamar-Cruz O; González-Montiel M; Barrios-García T; Cabrera-Quintero AJ; Rodríguez-Gómez G; Cancino-Villeda L; Zentella-Dehesa A; León-Del-Río A
    Front Endocrinol (Lausanne); 2020; 11():568375. PubMed ID: 33117284
    [TBL] [Abstract][Full Text] [Related]  

  • 66. KLF17 attenuates estrogen receptor α-mediated signaling by impeding ERα function on chromatin and determines response to endocrine therapy.
    Ali A; Ielciu I; Alkreathy HM; Khan AA
    Biochim Biophys Acta; 2016 Jul; 1859(7):883-95. PubMed ID: 27107895
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Alteration of ERalpha expression and tumor invasion by RNA interference against metastasis associated-1 gene in human breast cancer cells].
    Jiang QM; Zhang H; Zhang P
    Zhonghua Bing Li Xue Za Zhi; 2008 Feb; 37(2):118-23. PubMed ID: 18681324
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differential expression of a transcription regulatory factor, the LIM domain only 4 protein Lmo4, in muscle sensory neurons.
    Chen HH; Yip JW; Stewart AF; Frank E
    Development; 2002 Nov; 129(21):4879-89. PubMed ID: 12397097
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Repression of Lim only protein 4-activated transcription inhibits proliferation and induces apoptosis of normal mammary epithelial cells and breast cancer cells.
    Tian Y; Wang N; Lu Z
    Clin Exp Metastasis; 2010 Oct; 27(7):455-63. PubMed ID: 20526802
    [TBL] [Abstract][Full Text] [Related]  

  • 70. pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.
    Macaluso M; Cinti C; Russo G; Russo A; Giordano A
    Oncogene; 2003 Jun; 22(23):3511-7. PubMed ID: 12789259
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Glucocorticoid Receptor:MegaTrans Switching Mediates the Repression of an ERα-Regulated Transcriptional Program.
    Yang F; Ma Q; Liu Z; Li W; Tan Y; Jin C; Ma W; Hu Y; Shen J; Ohgi KA; Telese F; Liu W; Rosenfeld MG
    Mol Cell; 2017 May; 66(3):321-331.e6. PubMed ID: 28475868
    [TBL] [Abstract][Full Text] [Related]  

  • 72. LMO4 functions as a co-activator of neurogenin 2 in the developing cortex.
    Asprer JS; Lee B; Wu CS; Vadakkan T; Dickinson ME; Lu HC; Lee SK
    Development; 2011 Jul; 138(13):2823-32. PubMed ID: 21652654
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The estrogen receptor alpha:insulin receptor substrate 1 complex in breast cancer: structure-function relationships.
    Sisci D; Morelli C; Cascio S; Lanzino M; Garofalo C; Reiss K; Garcia M; Russo A; Andò S; Surmacz E
    Ann Oncol; 2007 Jun; 18 Suppl 6():vi81-5. PubMed ID: 17591841
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Heat shock factor 1 represses estrogen-dependent transcription through association with MTA1.
    Khaleque MA; Bharti A; Gong J; Gray PJ; Sachdev V; Ciocca DR; Stati A; Fanelli M; Calderwood SK
    Oncogene; 2008 Mar; 27(13):1886-93. PubMed ID: 17922035
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Estrogen receptor-α, RBCK1, and protein kinase C β 1 cooperate to regulate estrogen receptor-α gene expression.
    Gustafsson Sheppard N; Heldring N; Dahlman-Wright K
    J Mol Endocrinol; 2012 Dec; 49(3):277-87. PubMed ID: 23042805
    [TBL] [Abstract][Full Text] [Related]  

  • 76. SIP1/NHERF2 enhances estrogen receptor alpha transactivation in breast cancer cells.
    Meneses-Morales I; Tecalco-Cruz AC; Barrios-García T; Gómez-Romero V; Trujillo-González I; Reyes-Carmona S; García-Zepeda E; Méndez-Enríquez E; Cervantes-Roldán R; Pérez-Sánchez V; Recillas-Targa F; Mohar-Betancourt A; León-Del-Río A
    Nucleic Acids Res; 2014 Jun; 42(11):6885-900. PubMed ID: 24771346
    [TBL] [Abstract][Full Text] [Related]  

  • 77. RNF8 identified as a co-activator of estrogen receptor α promotes cell growth in breast cancer.
    Wang S; Luo H; Wang C; Sun H; Sun G; Sun N; Zeng K; Song H; Zou R; Zhou T; Cong R; Liu W; Yang L; Li D; Zhou X; Zhong X; Lin L; Jiao J; Yan G; Wang X; Min X; Cao L; Zhao Y
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1615-1628. PubMed ID: 28216286
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Contribution of DEAF1 structural domains to the interaction with the breast cancer oncogene LMO4.
    Cubeddu L; Joseph S; Richard DJ; Matthews JM
    PLoS One; 2012; 7(6):e39218. PubMed ID: 22723967
    [TBL] [Abstract][Full Text] [Related]  

  • 79. LMO4 controls the balance between excitatory and inhibitory spinal V2 interneurons.
    Joshi K; Lee S; Lee B; Lee JW; Lee SK
    Neuron; 2009 Mar; 61(6):839-51. PubMed ID: 19323994
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Estrogen receptor (ER) beta or p53 attenuates ERalpha-mediated transcriptional activation on the BRCA2 promoter.
    Jin W; Chen Y; Di GH; Miron P; Hou YF; Gao H; Shao ZM
    J Biol Chem; 2008 Oct; 283(44):29671-80. PubMed ID: 18765668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.